Daniel C. Javitt, 10% Owner at NRX Pharmaceuticals, Inc. (NRXP), sold 49,200 shares at $1.01 ($50K) on 2022-11-11, disclosed to the SEC on 2022-11-15.
Scheduled sale ($50k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| NRXP | SELL | 2022-08-02 | $1.6M | — | Filing → |
| NRXP | SELL | 2022-06-07 | $608K | — | Filing → |